AERI Market Cap History
Below is a table of the AERI market cap history going back to 10/25/2013:

Date AERI Market Cap

Also see: AERI Shares Outstanding History
and AERI YTD Return
AERI Historical Market Cap:
+11.07% CAGR
AERI Historical Market Cap: +11.07% CAGR

Mouse over chart for data details
10/25/2013 ...10/29/2021
Aerie Pharmaceuticals is an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of therapies for the treatment of patients with open-angle glaucoma, ocular surface diseases and retinal diseases. Co.'s commercial products include Rhopressa®, which is a once-daily eye drop to lower elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension; and Rocklatan®, which is a once-daily fixed-dose combination of Rhopressa® and latanoprost, the prescribed drug for the treatment of patients with open-angle glaucoma. Co. is developing three sustained-release implants focused on retinal diseases, AR-1105, AR-13503 SR and AR-14034 SR. We show 35 historical shares outstanding datapoints in our AERI shares outstanding history coverage, used to compute AERI market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing AERI market cap history over the course of time is important for investors interested in comparing AERI's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of AERI versus a peer is one thing; comparing AERI market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like AERI can fluctuate over the course of history. With this page we aim to empower investors researching AERI by allowing them to research the AERI market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree AERI Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Aerie Pharmaceuticals (AERI) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

AEZS Market Cap History
AFIB Market Cap History
AGEN Market Cap History
AGIO Market Cap History
AGL Market Cap History
AGLE Market Cap History
AGN Market Cap History
AGRX Market Cap History
AGTC Market Cap History
AGTI Market Cap History
More Healthcare companies »


AERI Market Cap History | | Copyright © 2017 - 2021, All Rights Reserved

Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.